The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

UK MHRA grants marketing approval to Galderma’s nemolizumab to treat prurigo nodularis and atopic dermatitis: United Kingdom Tuesday, February 18, 2025, 14:00 Hrs [IST] The Medi ...

Valneva SE (“Valneva”) announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency (MHRA) ...

UK MHRA approves Sobi’s efanesoctocog alfa to prevent and treat bleeding in children and adults with severe or moderate haemophilia A: United Kingdom Monday, February 17, 2025, ...

announces the receipt of the Medicines & Healthcare products Regulatory Agency (MHRA) approvals for the FemaSeed ® Intratubal Insemination product for female infertility treatment and two ...

Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

New Partnership for Africa’s Development (AUDA-NEPAD) and the Africa Centres for Disease Control and Prevention (Africa CDC) have taken a major step in improving regulatory systems across the ...